机译:Foreword: hepatocellular carcinoma: emerging treatments, drug targets, and fundamental knowledge gaps
Struttura Semplice Dipartimentale Oncol Med Presa,IRCCS Ist Tumori Giovanni Paolo II;
Hepatocellular carcinoma; Immunotherapy; Atezolizumab; Bevacizumab; Lenvatinib; pembrolizumab; Camrelizumab; Durvalumab; transarterial chemoembolization; immunotherapy;